Stayble Therapeutics (Sweden) Market Value
| STABL Stock | SEK 0.37 0.01 2.63% |
| Symbol | Stayble |
Stayble Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Stayble Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Stayble Therapeutics.
| 05/17/2025 |
| 08/15/2025 |
If you would invest 0.00 in Stayble Therapeutics on May 17, 2025 and sell it all today you would earn a total of 0.00 from holding Stayble Therapeutics AB or generate 0.0% return on investment in Stayble Therapeutics over 90 days. Stayble Therapeutics is related to or competes with Imugene, and Sprint Bioscience. Stayble Therapeutics AB develops injectable treatment for chronic low back pain triggered by disc degeneration More
Stayble Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Stayble Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Stayble Therapeutics AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.64 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 34.62 | |||
| Value At Risk | (7.14) | |||
| Potential Upside | 7.32 |
Stayble Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Stayble Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Stayble Therapeutics' standard deviation. In reality, there are many statistical measures that can use Stayble Therapeutics historical prices to predict the future Stayble Therapeutics' volatility.| Risk Adjusted Performance | 0.0101 | |||
| Jensen Alpha | 0.1315 | |||
| Total Risk Alpha | (0.60) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | (0.0005) |
Stayble Therapeutics Backtested Returns
Currently, Stayble Therapeutics AB is out of control. Stayble Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of close to zero, which indicates the firm had a close to zero % return per unit of risk over the last 3 months. We have found thirty technical indicators for Stayble Therapeutics AB, which you can use to evaluate the volatility of the company. Please validate Stayble Therapeutics' Coefficient Of Variation of 49938.45, risk adjusted performance of 0.0101, and Semi Deviation of 3.6 to confirm if the risk estimate we provide is consistent with the expected return of 0.0109%. The entity has a beta of -1.65, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Stayble Therapeutics are expected to decrease by larger amounts. On the other hand, during market turmoil, Stayble Therapeutics is expected to outperform it. Stayble Therapeutics right now has a risk of 5.42%. Please validate Stayble Therapeutics downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to decide if Stayble Therapeutics will be following its existing price patterns.
Auto-correlation | 0.02 |
Virtually no predictability
Stayble Therapeutics AB has virtually no predictability. Overlapping area represents the amount of predictability between Stayble Therapeutics time series from 17th of May 2025 to 1st of July 2025 and 1st of July 2025 to 15th of August 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Stayble Therapeutics price movement. The serial correlation of 0.02 indicates that only 2.0% of current Stayble Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.02 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Stayble Therapeutics lagged returns against current returns
Autocorrelation, which is Stayble Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Stayble Therapeutics' stock expected returns. We can calculate the autocorrelation of Stayble Therapeutics returns to help us make a trade decision. For example, suppose you find that Stayble Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Stayble Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Stayble Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Stayble Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Stayble Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Stayble Therapeutics Lagged Returns
When evaluating Stayble Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Stayble Therapeutics stock have on its future price. Stayble Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Stayble Therapeutics autocorrelation shows the relationship between Stayble Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Stayble Therapeutics AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Stayble Stock Analysis
When running Stayble Therapeutics' price analysis, check to measure Stayble Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stayble Therapeutics is operating at the current time. Most of Stayble Therapeutics' value examination focuses on studying past and present price action to predict the probability of Stayble Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stayble Therapeutics' price. Additionally, you may evaluate how the addition of Stayble Therapeutics to your portfolios can decrease your overall portfolio volatility.